AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

STRT Holding Nyilvánosan Működő Részvénytársaság

Investor Presentation Nov 26, 2025

14800_rns_2025-11-26_269ff968-32c6-4e22-9bf8-8deb7bfb3624.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

STRT HOLDING INVESTOR PRESENTATION

November 2025

This presentation constitutes advertising material. The prospectus relating to the initial public offering of the shares and their admission to trading on a regulated market was approved by the Central Bank of Hungary (Magyar Nemzeti Bank - CBH) pursuant to its Resolution No. H-KE-III-799/2025, dated 19. November 2025. The approval of the prospectus by the CBH shall not be construed as an endorsement of the securities to be offered or admitted to trading.

The original version of this presentation, as well as the prospectus prepared and approved in connection with the offering and admission of the shares to trading, are available in the Hungarian language only. The offering and admission to trading will take place in Hungary. In the event of any discrepancy be tween the Hungarian and English versions of this presentation, the Hungarian version shall prevail.

The prospectus is available on, and may be downloaded in electronic form from, the websites operated for capital markets disclosure purposes by STRT Holding Nyrt., as issuer, K&H Értékpapír, as distributor, the Budapest Stock Exchange Nyrt. and the CBH, at the following link: https://www.bet.hu/site/newkib/hu/2025.11./STRT\Holding\_Nyrt.\- \_Rendkivuli\_tajekoztatas\_129353460 . Prospective investors are urged to read the prospectus carefully before making any investment decision, in order to evaluate the risks and merits associated with an investment in the securities.

Additional information and terms relating to account opening are set forth in the General Business Rules and the List of Conditions of K&H Értékpapír, the applicable product agreements and the annexes thereto, each of which is available at https://www.khertekpapir.hu/ugyfeltamogatas/dokumentumok . Licence reference number: 2009/10240/570; case number: Sp/2009/614/571.

INTRODUCTION

Petya Balogh, CEO

STRT VISION

More internationally successful Hungarian & regional companies

Building entrepreneurial know-how

Financing big ambitions

Becoming a key player in the region

STRT OPERATIONS

Early-stage startup investment

Diverse segments: risk vs. return/growth

Diversified risk: large number of portfolio companies

Executive education and mentoring

Internally: enhancing portfolio companies' success

Externally: strengthening entrepreneurial culture

Stable revenue and cash generation

WHY NOW?

The downturn of the Hungarian venture capital market

Record-low company valuations

Limited competition for the best companies

Higher long-term return potential

Unfilled roles in the ecosystem

Opportunity to secure a market-leading position

Shaping the narrative and the market

WHY US?

Over a hundred investments Expertise and experienced team High market confidence in the profession We do it, learn it, and teach it Strong network of contacts

WHY GO PUBLIC?

A quasi new "asset class"

Lower entry barrier

Liquidity potential

Regulated market with transparent operations

Funding opportunities

INVESTMENTS

Péter Langmár, CIO

EARLY STAGE

No significant revenue yet Not yet profitable Requires external financing Innovating in a new field Typically international plans High valuation potential

EARLY-STAGE STARTUP INVESTMENTS

High individual risk

High failure rate

Completely illiquid

10+ year horizon

Requires expertise

INCUBATORS & INVESTORS

Major global examples

Smart money and support

Diversified portfolio

Scalable business models

Economies of scale

Techstars 5,513
Y Combinator 5,449
National Science Foundation 4,350
EASME - EU Executive Agenc 3,678
500 Global 3,059
MC MassChallenge 3,033
SUSV SOSV 2,555
New Enterprise Associates 2,117
Accel 1,919

Technological and market innovation Internationally scalable

Industry-agnostic

  • Med/HealthTech
  • AI

  • ➤ B2B/B2C SaaS
  • EduTech

  • AgriTech

  • Retail

HOW WE INVEST

High number of investments, strong diversification

"Evergreen", patient investor

Among the first investors

Small ticket sizes, up to ~HUF 40 million

Almost always co-investing

Standardized terms and processes

Already invested in foreign companies

INVESTMENTS

PORTFOLIO VALUE BY MARKET SEGMENT (2025 H1)

Alke Pro

imagi

#Labs

III\ KARANYI SOUNDS

Quest

MedRes

Antavo

Cricks Farm

CX-Rwy

Academy

C Qvezi

🌡 aprently

Argus Cognitive Barbell Notes

dicomLAB

DicomLab

DIFFUSEDRIVE

DiffuseDrive

indivizo+

Healmindset.

Healmindset

ImagiLabs

redmenta

Redmenta

Mikromester

Molin.ai

Munch

) Beholder

Aprently

bene: studio

Bene Studio

Bindr

DreamJobs

Dream(o.bs Eco Tiny House

Indiviso

Jógakaland

Karányi Sounda

PERSONED TONO

ROKSH7

Boksh

Smartbulldecolo

PÉXENT

MyMedio

MUNCH

*****

BIK Hungary Kft.

Beholder

Diversum

Komponion Care

Speedeo

StoriesOnBoard / DevMade

Stycut

Openmeter

MyForm

Courtifeter

branc:

Calibur

Systems

logiscool

Alkette.

Programosis

Opp.lo

CardioSight

cleango

Genomate

Lifty

Lightyear Logiscool

PastPay

PetwiseCare

Carbon Crane

Proofminder

INVESTMENT PLANS

Strong deal flow, limited capital

Foreign portfolio companies

  • Partial acquisition of angel and accelerator portfolios
  • Scale-up secondaries, e.g. Antavo
  • LP investments

Expanding co-investor partnerships

STRT Venture Capital Fund Manager

  • Higher assets under management
  • Follow-up investments
  • Economies of scale

EDUCATION

Mária Balogh-Mázi

Leaders:

  • ⮚ Company executives
  • ⮚ Senior executives
  • ⮚ Startup founders
  • ⮚ Corporate leaders

Professionals:

  • ⮚ Tech experts (AI, Python)
  • ⮚ Marketing
  • ⮚ HR
  • ⮚ Finance
  • ⮚ ...

Al and Innovation

Al course for leaders

Al practical workshop for leaders

Al PRO course for leaders

Al PRO practical workshop for leaders

Al & Law: The survivor's guide for leaders

Sales and Marketing

B2B marketing

Effective marketing strategy

LinkedIn presence for leaders

Sales automation

Strategy and Finance

Data-driven decision making

Successful webshop

International market entry

Course for (aspiring) angel investors

Crisis-proof business

Launch (e-learning)

Capital raising for startups (e-learning)

Personal Development

Assertive communication

  • Standing up.

Communication.

Connection.

In balance: stress management and burnout prevention

Mental health for leaders

Tricky negotiation situations

Personal branding for leaders

Personal branding workshop

Master-level negotiation technique

Conscious efficiency

Organizational Development

Summer turbocharge for company leaders Autumn turbocharge for company leaders

Master the change

DATA & TECHNOLOGY

AI FOR BUSINESS

DATA SCIENCE

AI TECHNOLOGY

PYTHON BASICS

DATA VISUALIZATION

INDUSTRY 4.0

AGILE METHODS

SCRUM MASTER ONLINE

PRODUCT OWNER MASTERCLASS

DESIGN THINKING

DIGITAL INNOVATION

SCRUM MASTER TRAINING

AGILE TRANSFORMATION

LEADERSHIP & STRATEGY

OKR: STRATEGY EXECUTION MADE

SIMPLE

AGILE JETPACK FOR LEADERS

E-COMMERCE

AGILE HR IN THE DIGITAL ERA

ELITE ATHLETES' TOOLKIT FOR EXECUTIVES

COLLABORATIVE FAMILY BUSINESS

BUSINESS STRATEGY PLANNING

AI FOR BUSINESS

ONLINE COURSES

PROMPTS FOR BREAKFAST

SCRUM MASTER ONLINE

GOOGLE ANALYTICS 4

AI IN MARKETING

AI IN RECRUITMENT

AI IN DIAGNOSTICS

EDUCATIONAL RESULTS

2025 H1

  • +63% revenue vs. 2024 H1
  • 1,600+ participants
  • Integration of Kürt Academy
  • Launch of the Season Pass product

2020–2022: sum of audited standalone figures of group member companies 2023–2024: consolidated audited figures of the group

FINANCIALS

István Nagy, CFO

IMPORTANT INFORMATION

Starting from fiscal year 2025, the Company applies the International Financial Reporting Standards (IFRS).

The Company has also completed the IFRS audit of financial statements for 2023 and 2024, which were originally prepared under Hungarian Accounting Standards.

Figures presented:

2020-2022: audited standalone figures prepared in accordance with the Hungarian Accounting Act (nonconsolidated)

2023-2024: audited consolidated figures prepared in accordance with IFRS

2025 H1: IFRS-based consolidated figures reviewed by the auditor

All figures are in thousands of HUF unless otherwise indicated.

2025 H1 IS: GROWTH FOCUS

  • Revenue: HUF 724 million, up 58.0%
  • Of which one-off impact: due to a change in the investment valuation methodology: +HUF 52.1 million (underlying growth: +49% without this effect)
  • ⅔ investments, ⅓ education
  • Operating profit: HUF 233 million, up 9.4%
  • Lower operating margin due to a significant increase in material-type expenses, primarily driven by the engagement of external lecturers in the education division
  • Personnel expenses increased due to team expansion and full-year impact
  • The education division's current focus is the integration of Kürt; efficiency improvements will follow
  • Profit after tax: HUF 187 million, up 1.2%
  • Treasury result: higher interest income, BUT foreign exchange losses
  • 99% of the tax expense is deferred tax

<-- PDF CHUNK SEPARATOR -->

2025 H1: EQUITY-FINANCED GROWTH

Total assets: HUF 4,486 million, up 19.2%

Assets side:

Investment portfolio: HUF 3,755 million, change: HUF +635 million (+20.4%)

Assets under management: HUF 4,120 million, change: HUF +744 million (+22.1%)

Equity and liabilities side:

Equity: HUF 3,927 million, change: HUF +589 million (+17.7%)

Retained earnings: +890%

INDICATORS PER SHARE

2025 H1 2024 FY 2024 H1 2023 FY
IFRS IFRS IFRS IFRS
Weighted arithmetic mean of outstanding common shares 5,241,771 4,703,057 4,443,061 3,296,448
Total comprehensive income (thousand HUF) 187,143 225,551 184,860 (95,950)
Diluted earnings per share (HUF) 35.70 47.96 41.61 (29.11)
Outstanding common shares at the end of the period 5,485,766 5,073,027 4,443,061 4,443,061
Equity (thousand HUF) 3,927,484 3,338,042 2,660,047 2,475,187
Diluted equity per share (HUF) 716 658 599 557
  • Since the Company's capital raisings precede the investments and their appreciation, EPS decreases.
  • This can be offset (later) by higher profitability in education and a possible future increase in the value of investments.
  • Equity per share has grown steadily in recent years.

EDUCATION REVENUE GROWTH

PORTFOLIO VALUE GROWTH

*: Includes shares, equity interests, SAFE-type investments, convertible loans and shareholder loans, but excludes the results of associated companies

**: Includes accrued interest on loans and the effects of foreign-exchange revaluations

INVESTMENT VALUATION METHODOLOGY

Audited methodology, applied retrospectively

Investment lifecycle:

  • At the time of investment: acquisition cost
  • After the next funding round: transaction-based valuation latest post-money valuation, reflecting preferential rights
  • After 2 years: market-comparable valuation multiples-based (P/S), considering industry, growth, country risk and preferential rights
  • Devaluation: impairment based on financial performance, business performance or significant risk (0%, 25%, 50%, 75%)

INVESTMENT

Tech and Market Innovation Across diverse industries High number of small-ticket investments

PORTFOLIO

Investment portfolio: HUF 3,755 million 2025 H1 Δ: +HUF 635 million (+20.4%)

VISION

More internationally successful Hungarian and regional companies Building entrepreneurial know-how

IPO

24 Nov – 5 Dec 2025

Price range: HUF 900–1,100

EDUCATION

Supporting portfolio companies Deepening entrepreneurial culture Stable revenue and cash flow

2025 H1 RESULTS

Revenue: HUF 724 million (+58.0%)

Operating profit: HUF 233 million (+9.4%)

PUBLIC OFFERING

Timing: 24 November – December 2025

Price range: HUF 900–1,100

Arranger: K&H Securities (Patria Finance)

In the event of any discrepancy between the Hungarian and English versions of this presentation, the Hungarian version shall prevail. The prospectus relating to the introduction of the issuer and its related companies, and the initial public offering of the shares was approved by the Central Bank of Hungary (Magyar Nemzeti Bank - CBH) pursuant to its Resolution No. H-KE-III-799/2025, dated 19. November 2025. The approval of the prospectus by the CBH shall not be construed as an endorsement of the securities to be offered or admitted to trading on the regulated market. The public offering shall not be regarded as investment advice, nor as financial or investment analysis. Prospective investors are urged to read the prospectus carefully before making any investment decision, in order to evaluate the risks and merits associated with an investment in the securities.

Let us work together to shape the future of Hungarian innovation!

ANNEX

PORTFOLIO MANAGEMENT

Individual mentoring

Trainings

Portfolio events

Support for next-round financing

EXAMPLES

Munch – Food rescue

  • "Cápák között" show
  • M&A activity in the Czech market
  • International venture capital round

PastPay - B2B BNPL

  • EUR 12m growth financing
  • Regional champion

OpenMeter – Pricing data analytics

  • Y Combinator, Haystack, Sunflower Capital
  • USD 3m seed round

MedRes – Medical device development

  • World-class quality, multiple spin-off exits
  • Parent company + 3 spin-off investments
  • CardioSight, Thermosurgery, ArgusCognitive

P&L: 2025 H1 vs 2024 H1

2025 H1 2024 H1 Change Percentage of
sales revenue
COMPREHENSIVE INCOME STATEMENT IFRS IFRS 2025 H1 vs 2024 H1 2025 H1
Revaluation of financial instruments 481,990 288,030 67.3 62.9
Gains or losses on the sale of investments 5,106 24,925 -79.5 5.4
Dividend income - - n.a. n.a.
Revenue from education and mentoring 236,667 145,065 63.1 31.7
Revenue
from
main activity
723,763 458,020 58.0 100.0
Capitalized own work 40,055 31,499 27.2 6.9
Material expenses (231,343) (107,066) 116.1 -23.4
Personnel expenses (240,872) (157,470) 53.0 -34.4
Depreciation (53,394) (27,912) 91.3 -6.1
Other expenses, net (4,502) 16,464 -127.3 3.6
Operating profit 233,707 213,535 9.4 46.6
Financing expenses 1,101 1,885 -41.6 0.4
Pre-tax profit 234,808 215,420 9.0 47.0
Income tax expense (47,665) (30,560) 56.0 -6.7
Profit after tax 187,143 184,860 1.2 40.4

B/S: 2025 H1 vs 2024 FY

2025 H1 2024 FY Változás Mérlegfőösszeg %-a
ESZKÖZÖK IFRS IFRS 2025 H1 vs 2024 H1 2025 H1
Befektetett eszközök 4,043,455 3,417,845 18.3% 90.1%
Egyéb immateriális eszközök 194,059 190,641 1.8% 4.3%
Használati jogi eszköz 53,891 63,654 -15.3% 1.2%
Ingatlanok 24,917 29,797 -16.4% 0.6%
Gépek, berendezések, járművek 14,920 13,409 11.3% 0.3%
Valós értéken eredménnyel szemben értékelt, hosszú lejáratú
értékpapírok
3,606,578 2,936,066 22.8% 80.4%
Valós értéken eredménnyel szemben értékelt, hosszú lejáratú
konvertálható kölcsönök
148,621 184,052 -19.3% 3.3%
Halasztott adó követelés 469 226 107.5% 0.0%
Forgóeszközök 442,626 346,886 27.6% 9.9%
Készletek 304 - n.a. 0.0%
Vevőkövetelések 6,166 17,120 -64.0% 0.1%
Rövid lejáratú eredménnyel szemben valós értéken értékelt
értékpapírok
296,740 226,133 31.2% 6.6%
Követelések kapcsolt vállalkozással szemben 20,520 18,956 8.3% 0.5%
Nyereségadó követelések - - n.a. n.a.
Egyéb követelések és időbeli elhatárolások 50,610 55,145 -8.2% 1.1%
Pénzeszköz és egyenértékeseik 68,286 29,532 131.2% 1.5%
Eszközök összesen 4,486,080 3,764,731 19.2% 100.0%

B/S: 2025 H1 vs 2024 FY

2025 H1 2024 FY Change % of Total Assets
EQUITY AND LIABILITIES IFRS IFRS 2025 H1 vs 2024 H1 2025 H1
Equity 3,927,484 3,338,042 17.7% 87.5%
Share capital 548,577 507,303 8.1% 12.2%
Capital reserve 3,174,508 2,813,482 12.8% 70.8%
Retained earnings 208,157 21,015 890.5% 4.6%
Owner transactions (3,758) (3,758) 0.0% -0.1%
Non-current liabilities 296,188 277,703 6.7% 6.6%
Deferred income 62,260 81,000 -23.1% 1.4%
Deferred tax liability 195,827 148,623 31.8% 4.4%
Non-current lease liabilities 38,101 48,080 -20.8% 0.8%
Current liabilities 262,408 148,986 76.1% 5.8%
Advances received from customers 37,978 30,763 23.5% 0.8%
Trade payables 58,760 36,059 63.0% 1.3%
Income tax liability 2,936 8,467 -65.3% 0.1%
Current lease liabilities 19,582 18,844 3.9% 0.4%
Other current liabilities and accruals 143,153 54,853 161.0% 3.2%
Total equity and liabilities 4,486,080 3,764,731 19.2% 100.0%

2025 H1 EDUCATION REVENUE SPLIT

2025 FUNDRAISING & ACQUISITION

2025 H1

• Capital Increase 1:

May 2025 – 412,739 "A" series ordinary shares

Total value: HUF 403.4 million

2025 H2 to date

  • Capital Increase 2 Secondary (non-cash) Acquisition of an investment July 2025 – 60,267 "A" series ordinary shares Total value: HUF 60.7 million
  • Capital Increase 3 July 2025 – 60,000 "A" series ordinary shares Total value: HUF 60 million
  • Capital Increase 4 MRP* (non-cash) August 2025 – 104,245 "A" series ordinary shares Total value: HUF 100 million

2025 YtD SUM: HUF 624.1 million

MEMBERS OF THE BOARD AND SUPERVISORY BOARD

Mária Balogh-Mázi CMO, Head of Education

Péter Balogh CEO

István Nagy CFO

Péter Langmár Chief Investment Officer

András P. Tóth CTO

Judit Budai Board Member

Viktória Dr. Hümpfner Supervisory Board Member

Zsuzsanna Palainé Fekete Supervisory Board Member

István Attila Köcse Supervisory Board Member

Béla Seres Supervisory Board Member

Talk to a Data Expert

Have a question? We'll get back to you promptly.